Endometriosis now has its own fertility pathway in NICE guidance
The updated fertility guideline includes a brand-new section specifically for those with endometriosis who are struggling to conceive.
We produce useful and usable guidance for the NHS and wider health and care system.
Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
Latest from NICE
Changes to NICE’s cost-effectiveness thresholds take effect
NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments.
MHRA-NICE pathway opens for business – everything you need to know to get started
Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on licensing and value.
Injection for more than a million people to help prevent heart attacks and strokes recommended
People who have had a heart attack, stroke, or serious circulation problem in their legs, and who also carry excess weight, can now be offered a weekly injection to help protect them from a further life-threatening event, NICE has said.
Implementation and planning
Best practice resources for practitioners and commissioners.
Helping you define, improve and measure quality in health, public health and social care.
Resources and recommendations for adult and children’s social care, with example scenarios to help put them into practice.
Explore ways to plan, save money and make decisions on the best ways to use resources.
More ways we support you
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
The British National Formulary (BNF) provides information about the selection, prescribing, dispensing and administration of drugs.
With over 370 topics to choose from, clinical knowledge summaries (CKS) can provide quick answers to clinical questions.
Our patient decision aids (PDAs) include treatment options available, likely outcomes, benefits, harms and uncertainties.
